Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The sterile solution or lyophilized format supports compound stability during storage when maintained under appropriate laboratory conditions
+ BPC-157, TB-500, Semaglutide, Tirzepatide, CJC-1295, Ipamorelin, AOD-9604, GHK-Cu, Retatrutide, Sermorelin, Tesamorelin, GHRP-2, GHRP-6, Hexarelin, and Melanotan II
All Ingredients Are Small Dosages ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL CELLg8 Liposomal Delivery System has undergone 8 generations of development over the last two decades, leading to the current and most advanced iteration
Per Humana's pharmacy policy (effective 1/20/2025), coverage requires ALL of the following: [4] Moderate-to-severe OSA diagnosis (AHI 15 on polysomnogram or REI 15 on home sleep test) BMI 27 kg/m (lower threshold than FDA label's obesity requirement) Using Zepbound with lifestyle modifications (reduced-calorie diet + physical activity) NO diabetes diagnosis (type 1 or type 2)this is an exclusion criterion Use diagnosis code G47.33 for OSA as the primary diagnosis, with obesity as secondary
US$ 20.17
US$ 20.85
US$ 27.09
